jna reg presentation
DESCRIPTION
JNA DEAPCITTRANSCRIPT
![Page 1: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/1.jpg)
Juvenile Nasopharyngeal Angiofibroma
DEPCIT approach
Angus Shao
![Page 2: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/2.jpg)
Definition
• Rare, benign • Locally destructive fibrovascular tumour
JNA Otolaryngol Clin N Am 44 (2011) 989–1004
![Page 3: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/3.jpg)
Epidemiology
• Males• Teenage, young adult - range from 9 to 29
years (mean age, 15 years)• 0.05% ? of H&N tumours
• Extremely rare in female/ patient older than 25
JNA Otolaryngol Clin N Am 44 (2011) 989–1004
![Page 4: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/4.jpg)
Aetiology
• Unknown• Theories:
– Nonchromaffin paraganglionic cells– Vascular hamartoma (Girgis 1973)
– JNA stroma cells (Coutinho-Camillo 2008)
• Vascular endothelial growth factor receptor-2• Transforming growth factor beta 1• Insulin-like growth factor 2• Deletion of chr 17 (p53)
![Page 5: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/5.jpg)
Aetiology
• Hormonal Receptors (Montag 2006)
– Androgen– Estrogen
• Embryologic chondrocartilage of skull bones (Schiff 1959)
– Superior margin of sphenopalatine foramen– Trifurcation
• Palatine bone• Horizontal ala of vomer• Root of pterygoid process
![Page 6: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/6.jpg)
Origin
(Operative Techniques in Otolaryngology 1999; 10(2): 101-106.)
Controversial • Posterolateral nasal wall at
sphenopalatine foramen• Vidian canal
![Page 7: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/7.jpg)
Pathology
• Macro– well defined, mucosalised, red/purple lobulated
mass arising in the nasopharynx from the lateral wall, posterior to MT
![Page 8: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/8.jpg)
Pathology
• Micro– non-encapsulated, fibrous pseudocapsule– spindle/stellate cells in a rich collagen matrix– with vascular spaces devoid of elastic fibers (elastic lamina)
• Lack muscularis layer
– Partially androgen dependent• Receptors for testosterone, DHT, Androgen
– not useful in Tx
– B-catenin mutation• APC/B-catenin mutation in FAP• JNA 25 times more likely in FAP - controversial
(Hauptman 2007)
![Page 9: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/9.jpg)
Clinical
• Adolescent male• Unilateral nasal
obstruction most common• Recurrent epistaxis• Nasal mass
– Smooth, lobulated– Compressible– Purplish or reddish hue
(Operative Techniques in Otolaryngology 2011; 22(4):281-284.)
![Page 10: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/10.jpg)
Staging
• No universal staging system• Most commonly accepted:
– Radkowski(Radkowski 1996)
![Page 11: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/11.jpg)
Investigation
• Bloods• Biopsy??!!!!• Imaging
![Page 12: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/12.jpg)
Timing of surgery related to embolisation
• Within 24 hr negate the benefits of embolization, insufficient devascularization and tumor necrosis greater operative blood loss
• thrombus formation and multinucleated giant cell reaction within 7 days of embolization
• recanalization and partial revascularization can be observed in 30% of embolized vessels after 7 days
• Maximal tumour softening observed at 8 days
J NeuroIntervent Surg doi:10.1136/neurintsurg-2012-010350
![Page 13: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/13.jpg)
Treatment
• Surgical disease• Open vs Endoscopic
• Rtx (unresectable) / Chemotherapy(rarely)• Hormonal therapy• Observation? !
![Page 14: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/14.jpg)
Open Approach
• Transpalatal• Lateral Rhinotomy• Mandibular swing• Midfacial degloving
![Page 15: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/15.jpg)
Endoscopic
• Shift towards endoscopic approach in last 10 years
• Mostly for early disease • Endoscopic appropriate up to stage IIIA
tumors (Wormald 2003)
![Page 16: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/16.jpg)
Endoscopic Coblation Technique
![Page 17: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/17.jpg)
Annals of Otology, Rhinology & Laryngology 122(6):353-357.
![Page 18: Jna reg presentation](https://reader033.vdocuments.net/reader033/viewer/2022061523/55398e684a795971788b4978/html5/thumbnails/18.jpg)
Summary
• Benign rare but locally destructive disease in adolescent male
• Fibrovascular tumour originated at SPF/Vidian canal
• Surgery is the treatment of choice (most)• Shift to endoscopic approach with similar rate
of recurrence compared to open technique